Methods Prospective, non-randomised, interventional cohort case series. A total of 27 eyes
of 27 patients with diabetic macular oedema received an intravitreal injection of 4 mg (0.1 …

Purpose: To describe the 3‐year risk of cataract after intravitreal triamcinolone (IVTA)
injections for diabetic macular oedema and the outcomes of cataract surgery. Methods …

Purpose To investigate the progression of cataract after a high dose (25 mg) intravitreal
triamcinolone acetonide injection in patients with macular oedema secondary to diabetes …

Background The management of diabetic patients with refractory macular oedema or
patients with no adequate pre-operative view to administer laser treatment provide a …

Purpose: To evaluate long-term effects of anterior and posterior peribulbar injections of
triamcinolone acetonide on intraocular pressure (IOP) elevation and cataract development …

OBJECTIVE: To report 2-year safety and efficacy outcomes from a trial of intravitreal
triamcinolone acetonide (TA) injections (4 mg) in eyes with diabetic macular edema and …

PURPOSE: To assess cataract progression after intravitreal triamcinolone injection.
DESIGN: Retrospective, interventional, case-control study. METHODS: Forty-two phakic …

Aim: The efficacy and safety of repeated injections of intravitreal triamcinolone (IVTA) for
diabetic macular oedema is unclear, with results of previous reports conflicting. Methods …

Purpose To evaluate the effect of intravitreal triamcinolone in eyes with diabetic macular
oedema that had no previous laser treatment. Methods In all, 12 eyes of 12 patients with …

PURPOSE: To determine if intravitreal injection of triamcinolone acetonide is safe and
effective in treating diabetic macular edema unresponsive to prior laser photocoagulation …